NCT04397822View on ClinicalTrials.gov

COVID-19 : Study of INFLAmmasome and PLAtelets Functions

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

May 25, 2022

Study Completion Date

May 25, 2022

Conditions
COVID-19
Interventions
BIOLOGICAL

Blood samples

Blood samples will be collected in peripheral blood at the admission in intensive care unit or in standard care unit to compare platelet inflammasome NLRP3 and others markers

Trial Locations (1)

31059

CHU Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04397822 - COVID-19 : Study of INFLAmmasome and PLAtelets Functions | Biotech Hunter | Biotech Hunter